Dr. Srinath Pashikanti
College of Pharmacy
Idaho State University, USA
Assistant Professor
Email: pashsrin@isu.edu
Qualifications
2012-2014 Ph.D., Medicinal Chemistry, School of Pharmacy,
The University of Kansas, USA
2007-2011 M.S., Medicinal Chemistry, The University of
Kansas, USA
2005-2007 M.S., Chemistry, South Dakota State University,
USA
Publications (selected)
-
Foster, A., Li, Y., Runyan, S., Dinh, T., Venadas, S., Chen,
J., Pashikanti, S., Datta, A., Ehring, G., Staubli, U., Activity of the
enantiomers of erythro-3-hydroxyaspartate at glutamate transporters and NMDA
receptors, Journal of Neurochemisry, 2016, 136, 692 – 697.
-
Pashikanti, S., Sibley, C., Nguyen, M.K., Santos, W.L.,
Regio- and Stereoselective Copper (II)-Catalyzed Hydrosilylation of Activated
Allenes in Water: Access to Vinylsilanes, Organic Letters, 2016, 18, 2443-2446.
-
Pashikanti, S., Sibley, C., Nguyen, M. K., Santos, W.L.,
Copper (II)-Catalyzed (E)-Selective Hydrosilylation of Allenes, Synfacts, 2016,
12, 0836-0836.
-
Pashikanti, S., Boissonneault, G.A., Cervantes, D.L., Ex
vivo detection of histone H1 modified with advanced glycation end products,
Free Radical Biology and Medicine, 2011, 50, 1410 – 1416.
-
Pashikanti, S., de Alba, D.R., Boissonneault, G.A.,
Cervantes, D.L., Rutin Metabolites: Novel Inhibitors of Non-oxidative Advanced
Glycation End Products, Free Radical Biology and Medicine, 2010, 48, 656.
-
Cervantes, D.L., Pashikanti, S., Rutin derivatives as potent
AGE inhibitors and its relevance in diabetes complications, FASEB J., 2007, 21:
646.1.